Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05125939 · ClinicalTrials.gov registry record
Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study
A clinical trial of Colonoscopy and Adenoma Detection Rate, sponsored by Evergreen General Hospital, Taiwan.
- Recruiting
- Registry status
- 2,700
- Enrollment target
- 6
- Study locations
NCT05125939: Recruiting study of Colonoscopy and Adenoma Detection Rate, sponsored by Evergreen General Hospital, Taiwan.
NCT05125939 is a study of Colonoscopy and Adenoma Detection Rate that is actively recruiting participants, run by Evergreen General Hospital, Taiwan. The registered enrollment target is 2,700 participants, above the 367-participant average among 20 other Colonoscopy trials with a reported enrollment target (636% higher). The trial reports 6 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05125939, a study of Colonoscopy and Adenoma Detection Rate, is actively recruiting participants, sponsored by Evergreen General Hospital, Taiwan.
- RECRUITING
- Registry status
- 2,700 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications.
Primary Outcome
The proportion of participants undergoing a complete colonoscopy who have one or more adenomas detected
Conditions Studied
Interventions
- OTHER Comparison of ADR
Study Locations (6)
Other
- E-Da Dachang Hospital - Kaohsiung City
- E-Da Hospital - Kaohsiung City
- Keelung Chang Gung Memorial Hospital - Keelung
- Evergreen General Hospital - Taoyuan District
- Linkou Chang Gung Memorial Hospital - Taoyuan District
California
- Sepulveda Ambulatory Care Center, VAGLAHS - North Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,700 participants |
| Start Date | 2021-11-20 |
| Est. Completion | 2026-09-30 |
What NCT05125939 shows while recruiting
NCT05125939 is an observational study that tracks outcomes without assigning an intervention. Its 2,700 participants enrollment target places it among the larger protocols in the corpus, above the 367-participant average among 20 other Colonoscopy trials with a reported enrollment target (636% higher).
The record links to 2 conditions, with Colonoscopy appearing as the primary indexed condition, and to 1 intervention - of which Comparison of ADR is the first listed.
NCT05125939 lists 6 locations in 2 states (Other, California).
Frequently Asked Questions
What is clinical trial NCT05125939 about?
NCT05125939 is a clinical study titled "Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study". This is a prospective equivalence colonoscopy study evaluating whether overall adenoma detection rate (ADR) is a reliable alternate for screening ADR. Overall indication includes screening, surveillance, and diagnostic indications.
What is the current status of trial NCT05125939?
This trial is currently recruiting. The enrollment target is 2,700 participants. The study started on 2021-11-20. Estimated completion is 2026-09-30.
What conditions does trial NCT05125939 study?
This clinical trial studies the following conditions: Colonoscopy, Adenoma Detection Rate.
What interventions are being tested in trial NCT05125939?
The interventions under investigation include: Comparison of ADR (OTHER).
Who is sponsoring clinical trial NCT05125939?
This trial is sponsored by Evergreen General Hospital, Taiwan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05125939 being conducted?
This trial has 6 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colonoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05125939's enrollment target sits among peer trials
2,700 1st of 20 higher than 20 of 20 other Colonoscopy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colonoscopy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
RECRUITING
-
Impact of Artificial Intelligence on Trainee Polyp Miss Rates
RECRUITING · NA
-
Cold Snare Endoscopic Mucosal Resection Trial
ACTIVE NOT RECRUITING · NA
-
A Phase III Study of the Efficacy and Safety of Remimazolam Compared to Placebo and Midazolam in Colonoscopy Patients
COMPLETED · Phase 3
-
Comparison of Oxygenation and Ventilation With a Novel Nasal Mask Versus Standard of Care During Colonoscopy
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04073420 · 2,700 participants
Medtronic Cardiac Surgery PMCF Registry
- NCT05586776 · 2,700 participants · Phase 4
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
- NCT06052267 · 2,700 participants · Phase 3
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
- NCT07029490 · 2,700 participants · NA
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI